Skip to main content

What the FDA labels say about taking them together

Methenamine and metolazone

Metolazone's FDA label of December 11, 2025 names methenamine in its drug interactions section; the methenamine labels PlainMeds reads (2) do not name metolazone. The metolazone label: “Methenamine Efficacy may be decreased due to urinary alkalizing effect of metolazone.”

Check it at the source: the methenamine FDA label on DailyMed (effective August 7, 2026, ANI Pharmaceuticals, Inc.); the metolazone FDA label on DailyMed (effective December 11, 2025, Unichem Pharmaceuticals (USA), Inc.).

What does the methenamine label say about metolazone?

Methenamine's label (effective August 7, 2026) and its 1 other brand-application label do not name metolazone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Methenamine Hippurate), ANI Pharmaceuticals, Inc., effective August 7, 2026 (SPL set a3eeacd4-1983-49ec-a60d-3abaf505ce57), via openFDA; the full label on DailyMed

What does the metolazone label say about methenamine?

Metolazone label, drug interactions

Methenamine Efficacy may be decreased due to urinary alkalizing effect of metolazone.

Source: FDA drug label (Metolazone), Unichem Pharmaceuticals (USA), Inc., effective December 11, 2025 (SPL set c6fe5426-a184-44b8-a555-621d72aa5b9f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Methenamine generic labelers
19Metolazone generic labelers
MethenamineMetolazone
Labeled forUrinary tract infectionsHigh blood pressure, Edema (fluid retention), Heart failure
Boxed warningNoNo
Pharmacy cost (NADAC)$0.313 per tablet 1 g tablet$0.233 per tablet 2.5 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?